Atlas Trials

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

Clinical trial NCT05990959 · UNKNOWN

Trial details

NCT number
NCT05990959
Sponsor
China Medical University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma RecurrentSurgery
Start date
2022-04-22
Primary completion
2025-12-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.